The FDA has granted fast-track approval to the drug telisotuzumab vedotin (sold as Emrelis) as a first-of-its-kind treatment for certain people who have non-squamous non-small-cell lung cancer.

I never thought in a million years that this would happen to me … especially so young,” Brooklynite Jaclyn Keely told The ...

Dr. Johnathan Whetstine researches cancer treatments at Temple's Fox Chase Cancer Center — a battle that's personal for him.

The test processes whole-slide images of non-small cell lung cancer tissue to provide a quantitative TROP2 score, which Roche says provides a level of precision beyond manual methods. TROP2 has ...

Raymond Osarogiagbon, MD, discusses the challenges of implementing lung cancer screening guidelines and the need for increased awareness and access. In this clip, Raymond Osarogiagbon, MD ...

The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced HER2-mutant non-small cell lung cancer – particularly those with specific HER2 ...

had surgery—a lobectomy—within days to remove the upper right lobe of her lung and more than 20 regional lymph nodes. Because the cancer was detected early, and had not spread, she did not require ...

All patients exhibited upper lobe predominance (right upper: 7; left upper ... Although several blood-based tests have been developed to help classify lung cancer, non-invasive and reliable methods ...

In summary, Zero-Stage Lung Cancer is highly treatable when caught early Veteran actor Sharmila Tagore revealed that she had quietly battled cancer in 2023. The news took many fans by surprise ...

Summit Therapeutics shares rallied after its lung cancer drug candidate showed that it improved patients' longevity without the disease worsening in a late-stage trial. Shares of Summit rose 11% ...